All News #Library
Biotech
Fresenius Kabi, TQ Therapeutics Partner On Cell Therapy Tech
14 Jan 2026 //
PRESS RELEASE
Fresenius Kabi Introduces New Presentation of Otulfi
06 Jan 2026 //
PRESS RELEASE
Fresenius Kabi Introduces Dalbavancin for Injection
24 Nov 2025 //
PRESS RELEASE
Fresenius Rolls Out Adaptive Nomogram at BioLife Centers
12 Nov 2025 //
PRESS RELEASE
FDA Grants Interchangeable Desig to Fresenius Kabi’s Biosimilar
29 Oct 2025 //
PRESS RELEASE
Fresenius Kabi Leads EASYGEN to Decentralize CAR-T Therapy
26 Aug 2025 //
PRESS RELEASE
Fresenius Receives FDA Approval for their Denosumab Biosimilars
28 Mar 2025 //
BUSINESSWIRE

Market Place
Sourcing Support